| The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit
organization that integrates leading academic institutions to accelerate
drug development in multiple myeloma. It is comprised of the MMRC and 13
member institutions: City of Hope Cancer Center, Dana-Farber Cancer
Institute, Emory University's Winship Cancer Institute, Hackensack
University Medical Center, H. Lee Moffitt Cancer Center & Research
Institute, Mayo Clinic, Ohio State University, Roswell Park Cancer
Institute, St. Vincent's Comprehensive Cancer Center of Saint Vincent
Catholic Medical Centers of New York, University Health Network (Princess
Margaret Hospital), University of Chicago, University of Michigan, and
Washington University |
